We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 30 november 2017

Nature Reviews Urology - Table of Contents alert Volume 14 Issue 12

If you are unable to see the message below, click here to view.
Nature Reviews Urology

Is your organization planning a scientific event or conference for 2018? 

Looking for a way to increase the number of attendees?

Advertise in the Natureevents Directory 2018. 

Available online and in print. Ad close deadline: 4 December, 2017 
December 2017 Volume 14 Number 12 Advertisement
Nature Reviews Urology cover
2016 2-year Impact Factor 7.735
In this issue
Research Highlights
News and Views
Consensus Statement
Also this month
 Featured article:
Frontiers in robot-assisted retroperitoneal oncological surgery
Wesley W. Ludwig, Michael A. Gorin, Phillip M. Pierorazio and Mohamad E. Allaf

Nature Reviews Disease Primers - Stay updated

Nature Reviews Disease Primers covers all medical specialties, already having published on more than 120 diseases and disorders since launching in 2015. With such a comprehensive article collection, our e-alerts are the perfect solution to stay updated on the latest content published by the journal.

Register for the e-alert

Recommend to library
Nature Outlook: Bladder cancer

After three decades without progress, there is now hope that we can move the needle on treating bladder cancer.

Access the Outlook free online for more

Produced with support from: 
Comment: Sacral neuromodulation and alterations in brain activity — discussing discrepancies
Bradley C. Gill & Howard B. Goldman

Published online: 14 November 2017
p697 | doi:10.1038/nrurol.2017.188

Sacral neuromodulation is used to treat refractory overactive bladder (OAB). Recent research has shown that changes in brain activity during sacral neuromodulation relate to its mechanism of action and that these changes vary with device settings. Much remains to be discovered about how sacral neuromodulation influences brain activity, but studies are now beginning to elucidate these effects.
Full Text | PDF


Prostate cancer: Response prediction with HSD3B1
Published online: 14 November 2017
p699 | doi:10.1038/nrurol.2017.192


Kidney cancer: AXL expression predicts prognosis
Published online: 08 November 2017
p700 | doi:10.1038/nrurol.2017.186


Pain: Long-term outcomes of TRMDSC for chronic orchialgia
Published online: 21 November 2017
p700 | doi:10.1038/nrurol.2017.197


Prostate cancer: The importance of the mitochondrial genome
Published online: 17 October 2017
p701 | doi:10.1038/nrurol.2017.174


Kidney cancer: PHGDH is key for targeting HIF in RCC
Published online: 08 November 2017
p702 | doi:10.1038/nrurol.2017.176


Bladder cancer: Context is key: dual roles of ANGPTL4
Published online: 14 November 2017
p702 | doi:10.1038/nrurol.2017.191




Prostate cancer: No benefit of combining custirsen with cabazitaxel | Testicular cancer: No activity of pembrolizumab in phase II trial | Prostate cancer: Brachytherapy monotherapy is efficacious | Prostate cancer: Treatment after ADT plus docetaxel

Nature Reviews Urology
JOBS of the week
PhD Positions in Cancer Research at the German Cancer Research Center
German Cancer Research Center (DKFZ).
Associate Senior Lecturer (Assistant Professor) in Molecular Medicine with focus on cancer
University of Gothenburg, Wallenberg Centre for Molecular and Translational Medicine
Distinguished Faculty Recruitment Program
University of Illinois
More Science jobs from
Nature Reviews Urology
The 4th Friends of Israel Urological Symposium
Tel Aviv, Israel
More science events from
Paediatrics: Integrating genomics to dig deeper into Wilms tumour biology
William Mifsud & Kathy Pritchard-Jones

Published online: 25 October 2017
p703 | doi:10.1038/nrurol.2017.178

A new study provides a comprehensive catalogue of the genetic changes in Wilms tumour. Understanding the interplay between genetic and epigenetic aberrations during tumorigenesis and clonal evolution is fundamental to enabling prediction of who is at risk and which tumours will relapse when so many are curable.
Full Text | PDF

Male factor infertility: Varicocele repair in the era of assisted reproductive technology
Mikkel Fode

Published online: 31 October 2017
p705 | doi:10.1038/nrurol.2017.182

A new publication finds that varicocele repair might improve semen quality enough to enable couples who are awaiting in vitro fertilization or intrauterine insemination to attempt natural conception or less-invasive assisted reproductive techniques. The approach is interesting because it seeks to establish varicocele treatment as one step in a multimodal path to parenthood.
Full Text | PDF

Microfluidics for sperm analysis and selection
Reza Nosrati et al.

Published online: 31 October 2017
p707 | doi:10.1038/nrurol.2017.175

Many emerging opportunities exist for microfluidics in male infertility diagnosis and treatment, and promising microfluidic approaches are under investigation for addressing male infertility. In this Review, the authors describe and discuss these approaches for sperm analysis and selection.
Abstract | Full Text | PDF | Supplementary information

Frontiers in robot-assisted retroperitoneal oncological surgery
Wesley W. Ludwig, Michael A. Gorin, Phillip M. Pierorazio & Mohamad E. Allaf

Published online: 12 September 2017
p731 | doi:10.1038/nrurol.2017.149

Owing to the limited operating space available, robot-assisted approaches have been rapidly adopted for procedures involving the retroperitoneal space. In this Review the authors describe the outcomes of patients undergoing robot-assisted procedures, including partial nephrectomy, radical nephrectomy, retroperitoneal lymph node dissection, nephroureterectomy and adrenalectomy, in addition to the potential of novel techniques.
Abstract | Full Text | PDF

Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol
Marry M. van den Heuvel-Eibrink et al.

Published online: 31 October 2017
p743 | doi:10.1038/nrurol.2017.163

The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP-RTSG) has developed a new protocol for the diagnosis and treatment of childhood renal tumours, the UMBRELLA SIOP-RTSG 2016 (the UMBRELLA protocol). In this Consensus Statement, members of SIOP-RTSG outline the rationale for the recommendations in the protocol.
Abstract | Full Text | PDF
Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials
Chris Blick, Alastair W. S. Ritchie, Timothy Eisen & Grant D. Stewart

Published online: 01 August 2017
p753 | doi:10.1038/nrurol.2017.123

Outcomes of patients with high-risk, localized renal cancer depend on optimal patient stratification, surgical management, and systemic therapy selection. Blick et al. discuss the current knowledge on these topics and provide an overview of interventions that are currently being investigated in clinical trials.
Abstract | Full Text | PDF

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
Nature Reviews Urology was previously published as Nature Clinical Practice Urology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature